Insider · CIK 0001328565

TETLOW SHARON

Reports to the SEC for 5 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001328565

Forms 4 and 5

Insider transactions

30 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-17	GPCRStructure Therapeutics Inc. · Share Option (right to buy)A Award	Director	AAward	+39.5K sh	—	—	39,453
2025-06-23	GPCRStructure Therapeutics Inc. · Share Option (right to buy)A Award	Director	AAward	+51.8K sh	—	—	51,804
2024-06-25	GPCRStructure Therapeutics Inc. · Share Option (right to buy)A Award	Director	AAward	+37.5K sh	—	—	37,500
2023-08-09	DICE Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−49.8K sh	—	—	0
2023-08-09	DICE Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.1K sh	—	—	0
2023-08-09	DICE Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,261 sh	—	—	0
2023-08-09	DICE Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.8K sh	—	—	0
2023-08-09	DICE Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−21.3K sh	—	—	0
2022-06-07	DICE Therapeutics, Inc.Stock Option (right to buy Common Stock)A Award	Director	AAward	+21.3K sh	—	—	21,250
2021-09-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+12.1K sh	—	—	12,096
2021-09-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+8,261 sh	—	—	8,261
2021-09-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+8,200 sh	—	—	8,200
2021-09-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+5,600 sh	—	—	5,600
2021-06-09	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+14K sh	—	—	14,000
2020-07-01	GYREGYRE THERAPEUTICS, INC.A Award	Director	AAward	+1,703 sh	—	—	3,635
2020-06-11	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2020-04-01	GYREGYRE THERAPEUTICS, INC.A Award	Director	AAward	+1,932 sh	—	—	1,932
2020-01-15	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2014-07-11	Ocera Therapeutics, Inc.P Purchase	Acting CFO & Treasurer	PPurchase	+3,000 sh	$5.83	+$17.5K	3,000
2009-10-14	CELL GENESYS INCD Disposition to Issuer	SVP & CFO	DDisposition to Issuer	−18.4K sh	—	—	0
2009-10-14	CELL GENESYS INCEmployee Stock Option (right to buy)D Disposition to Issuer	SVP & CFO	DDisposition to Issuer	−50K sh	—	—	0
2009-10-14	CELL GENESYS INCEmployee Stock Option (right to buy)D Disposition to Issuer	SVP & CFO	DDisposition to Issuer	−50K sh	—	—	0
2009-10-14	CELL GENESYS INCEmployee Stock Option (right to buy)D Disposition to Issuer	SVP & CFO	DDisposition to Issuer	−36.5K sh	—	—	0
2009-10-14	CELL GENESYS INCEmployee Stock Option (right to buy)D Disposition to Issuer	SVP & CFO	DDisposition to Issuer	−13.5K sh	—	—	0
2009-10-14	CELL GENESYS INCEmployee Stock Option (right to buy)D Disposition to Issuer	SVP & CFO	DDisposition to Issuer	−1,250 sh	—	—	0
2009-10-14	CELL GENESYS INCEmployee Stock Option (right to buy)D Disposition to Issuer	SVP & CFO	DDisposition to Issuer	−28.8K sh	—	—	0
2009-10-14	CELL GENESYS INCEmployee Stock Option (right to buy)D Disposition to Issuer	SVP & CFO	DDisposition to Issuer	−69K sh	—	—	0
2009-10-14	CELL GENESYS INCEmployee Stock Option (right to buy)D Disposition to Issuer	SVP & CFO	DDisposition to Issuer	−81K sh	—	—	0
2005-06-08	CELL GENESYS INCP Purchase	SVP & CFO	PPurchase	+2,500 sh	$4.91	+$12.3K	2,500
2005-06-01	CELL GENESYS INCStock Option (Rght to buy)A Award	SVP & CFO	AAward	+150K sh	—	—	150,000

Recent filings

Accepted (ET)
Jun 184
TETLOW SHARON0001328565-26-000002
SEC(opens sec.gov)
Jun 254
TETLOW SHARON0001415889-25-018214
SEC(opens sec.gov)
Jun 274
TETLOW SHARON0001415889-24-018325
SEC(opens sec.gov)
Aug 94
TETLOW SHARON0001209191-23-045194
SEC(opens sec.gov)
Jun 84
TETLOW SHARON0001209191-22-035089
SEC(opens sec.gov)
Sep 164
TETLOW SHARON0001209191-21-056525
SEC(opens sec.gov)
Jul 24
TETLOW SHARON0001209191-21-044692
SEC(opens sec.gov)
Jul 24
TETLOW SHARON0001209191-20-040405
SEC(opens sec.gov)
Jun 124
TETLOW SHARON0001209191-20-036316
SEC(opens sec.gov)
Apr 34
TETLOW SHARON0001209191-20-023199
SEC(opens sec.gov)
Jan 174
TETLOW SHARON0001209191-20-003942
SEC(opens sec.gov)
Jul 154
Ocera Therapeutics, Inc.0001104659-14-051612
SEC(opens sec.gov)
Oct 154
TETLOW SHARON0001235802-09-000107
SEC(opens sec.gov)

Companies

Address

C/O STRUCTURE THERAPEUTICS INC. 601 GATEWAY BLVD., SUITE 900

SOUTH SAN FRANCISCO, CA, 94080